Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Filipe Froes (Lisbon, Portugal), Madalena Martins, Filipe Froes, José M. Boavida, João F. Raposo, Baltazar Nunes, Rogério T. Ribeiro, M. Paula Macedo, Carlos Penha-Gonçalves. Prevalence and impact of Diabetes mellitus (DM) among hospitalized community-acquired pneumonia (CAP) patients. Eur Respir J 2015; 46: Suppl. 59, 1104

Member's Comments

No comment yet.

Related content which might interest you: Impact of diabetes mellitus on microbiological profiles of patients with community-acquired pneumonia in a central hospital Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Diabetes mellitus type 2 in patients with COPD admitted for exacerbation: Preliminary data Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Impact of diabetes mellitus on inflammatory markers and severity scales in community-acquired pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 The prevalence of cardiac diseases in patients with community-acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Impact of obesity on outcomes for patients hospitalised with pneumonia Source: Eur Respir J 2013; 41: 929-934 Year: 2013 Undiagnosed diabetes mellitus in community-acquired pneumonia - A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) Source: International Congress 2014 – Immunology of respiratory infections Year: 2014 Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Community-acquired pneumonia--Impacts of diabetes mellitus as a comorbidity: A prospective, observational study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Prevalence of diabetes mellitus in new tuberculosis cases in Baghdad Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Influence of comorbidities on pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 A study of immunogenetic markers associated With tuberculosis and diabetes mellitus Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Influence of chronic cardiovascular diseases (CVD) on course and outcome of community-acquired pneumonia (CAP) Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 The prevalence of smoking in HIV-infected patients with community-acquired pneumonia Source: International Congress 2015 – Epidemiology, public health and economics of tobacco Year: 2015 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Antibacterial therapy of community-acquired pneumonia (CAP) at patients with cardiovascular diseases (CVD) Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012